Raffles Medical Group (SGX:BSL) Beta: 0.7536 (As of Jul. 01, 2026)


SGX:BSL Raffles Medical Group Ltd SGX:BSL
87 GF Score
Price S$0.91
GF Value S$1.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Raffles Medical Group Beta?

Raffles Medical Group SGX:BSL -0.55% 87 Beta is 0.7536 as of Jul. 01, 2026. GuruFocus rates SGX:BSL with a GF Score™ of 87/100 and a GF Value™ of S$1.05 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-01), Raffles Medical Group's Beta is 0.7536.


Raffles Medical Group  (SGX:BSL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Raffles Medical Group Beta Related Terms


Raffles Medical Group Beta Historical Data

* Premium members only.

The historical data trend for Raffles Medical Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raffles Medical Group Beta Chart

Raffles Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.74 0.62 0.67 0.88

Raffles Medical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.70 0.67 0.81 0.88

SGX:BSL vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Raffles Medical Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raffles Medical Group Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Beta distribution charts can be found below:

* The bar in red indicates where Raffles Medical Group's Beta falls into.


SGX:BSL
87GF Score
Raffles Medical Group Ltd SGX:BSL
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raffles Medical Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7536 mean?
Raffles Medical Group (SGX:BSL) has a Beta of 0.7536 as of Jul. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Raffles Medical Group and its competitors.
Is Raffles Medical Group's Beta too high?
Raffles Medical Group's current Beta is 0.7536. Overall, Raffles Medical Group has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Beta compare to HCA and THC?
Raffles Medical Group's Beta of 0.7536 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Raffles Medical Group and its competitors. Raffles Medical Group's current Beta is 0.7536. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (SGX:BSL) is currently considered Modestly Undervalued. The stock's GF Value™ is S$1.05, compared to a current price of S$0.91 — trading 13.3% below its estimated fair value. The current Beta is 0.7536. Raffles Medical Group's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Raffles Medical Group (SGX:BSL), the current Beta is 0.7536 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raffles Medical Group (SGX:BSL) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued. The current stock price of S$0.91 is trading 13.3% below its estimated GF Value™ of S$1.05. GuruFocus considers Raffles Medical Group to be Modestly Undervalued.

Key valuation signals for SGX:BSL:

  • Beta: 0.7536
  • GF Value™: S$1.05 vs. price of S$0.91 (13.3% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the SGX:BSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raffles Medical Group Business Description

Other Exchanges RAFLF:USA
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
87GF Score

Get the complete analysis for SGX:BSL

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.91
Price
S$1.05
GF Value